Trade

Nephro Care India share price

  • NaN%Low risk
  • NaN%Moderate risk
  • NaN%Balanced risk
  • NaN%High risk
  • NaN%Extreme risk
  • 81.00(2.60%)
    May 21, 2026 15:08:42 PM IST
    • NSE
    • BSE
  • Vol : 12.40 K (NSE + BSE)
    Last 20 day avg : 17.46 K

Nephro Care India is trading 2.60% upper at Rs 81.00 as compared to its last closing price. Nephro Care India has been trading in the price range of 81.00 & 78.95. Nephro Care India has given -28.55% in this year & -0.75% in the last 5 days. Nephro Care India has TTM P/E ratio 64.56 as compared to the sector P/E of 29.62.Listed peers of Nephro Care India include Apollo Hospitals Enterprise (2.65%), Max Healthcare Institute (1.42%), Fortis Healthcare (-0.29%).The Mutual Fund holding in Nephro Care India was at -% in . The MF holding has - from the last quarter. The FII holding in Nephro Care India was at 0.73% in 31 Mar 2026. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on May 21, 2026, 02:44 PM UTC

  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.00
    Lower than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    -
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
78.95
Highest
81.00
52 week range
Lowest
50.05
Highest
183.00
Nephro Care India Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Apollo Hospitals Enterprise
Bullish
8,313.002.651,20,008.3072.4212.790.2783.18
Max Healthcare Institute
Moderately Bullish
1,091.551.421,06,293.6882.849.940.1629.50
Fortis Healthcare
Bullish
971.20-0.2973,246.3370.496.730.1325.92
Aster DM Healthcare
Bullish
756.00-1.0739,169.95100.15100.5853.36
Narayana Hrudayalaya
Bullish
1,928.701.3539,418.1741.539.160.2859.03
Nephro Care India Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-05-27Audited Results & Others
2026-02-13Quarterly Results & Others
2025-11-12Quarterly Results & Others
2025-07-10Others
2025-05-28Audited Results & Others
About the company Nephro Care India
  • IndustryHealthcare Facilities
  • ISININE0SUN01013
  • BSE Code
  • NSE CodeNEPHROCARE
Nephro Care India Limited is an India-based company that operates as a healthcare provider. Its business is to provide a comprehensive 360-degree healthcare service to patients with kidney-related services. It operates only in non-invasive service. It offers a range of clinical and lifestyle solutions and services and renal insufficiency treatment for patients. Its treatment framework covers the entire range of lifestyle, physiological and spiritual aspects of wellness. It provides holistic care for renal failure patients, which includes consultation, treatment, and yoga. It offers nutritional support for diabetic kidney disease, hypertensive nephropathy, glomerular disease, renal transplant recipient, hemodialysis patient, IgA nephropathy, Lupus nephropathy, and ADPKD. It operates various clinics, such as Renal Transplant, Urology, and Vascular Surgery. It also offers other services, such as Pulmonary function test, EMG/NCV-testing, Uroflowmetry, EEG, Polysomnography, and others.
  • Management Info
  • Pratim SenguptaExecutive Chairman, Chief Executive Officer, Managing Director
  • Tapas SahaChief Financial Officer
  • Arnab MajumderChief Operating Officer
  • Sougata SenguptaCompliance Officer, Company Secretary
Nephro Care India Share Price FAQs

Nephro Care India is trading at 81.00 as on Thu May 21 2026 09:38:42. This is 2.60% upper as compared to its previous closing price of 78.95.

The market capitalization of Nephro Care India is 133.54 Cr as on Thu May 21 2026 09:38:42.

The 52 wk high for Nephro Care India is 183.00 whereas the 52 wk low is 50.05

Nephro Care India can be analyzed on the following key metrics -

  • TTM P/E: 64.56
  • Sector P/E: 29.62
  • Dividend Yield: 0.00%
  • D/E ratio: 0.00

Nephro Care India reported a net profit of 3.64 Cr in 2025.